Please login to the form below

Not currently logged in
Email:
Password:

Asana appoints new chief medical officer

Louis Denis joins from Boehringer Ingelheim

Asana Biosciences has appointed Louis Denis as its new chief medical officer.

Denis is a medical oncologist with over 20 years of academic and industry experience in clinical cancer drug development.

He will be responsible for the overall strategic direction and medical oversight of clinical development of Asana's novel product candidates.

He said: “I am delighted to join Asana at this transformative time for the company.

“I look forward to working with the Asana team and its scientific advisory board to advance the company's broad portfolio of differentiated targeted therapies to help address major unmet medical needs.”

Denis has formerly held strategic and leadership positions at Boehringer-Ingelheim, where he headed the medical team, and Pfizer. 

Sandeep Gupta, president and chief executive officer of Asana Biosciences, said: “We are extremely pleased with the addition of Dr. Denis, a highly experienced physician and scientist, to our team. It represents a significant step in our evolution as an oncology-focused clinical development company.”

29th October 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics